Journals / Retina-Vitreus / 2012 / Cilt: 20 - Sayı: 4

Frequency of retinopathy of prematurity in preterm babies with a birth weight more than 1500 gram

Doğum ağırlığı 1500 gramdan fazla olan preterm bebeklerde prematüre retinopatisi sıklığı

Pages
279–282
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, even if preterm babies have a BW over 1500 g they still have considerable risk for development of ROP, particularly if they have additional systemic diseases or a history of supplementary oxygen treatment, and they should be examined regularly.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the frequency of retinopathy of prematurity (ROP) in preterm babies with a birth weight (BW) over 1500 g.
📊
Key Findings & Data:Material and Methods: The medical records of premature babies examined between July 2010 and June 2012 were retro - spectively evaluated.
💡
Conclusion & Impact:In conclusion, even if preterm babies have a BW over 1500 g they still have considerable risk for development of ROP, particularly if they have additional systemic diseases or a history of supplementary oxygen treatment, and they should be examined regularly.
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Purpose: To evaluate the frequency of retinopathy of prematurity (ROP) in preterm babies with a birth weight (BW) over 1500 g. Material and Methods: The medical records of premature babies examined between July 2010 and June 2012 were retro - spectively evaluated. Babies with a BW over 1500 g were enrolled to the study. BW, gestational age (GA), onset and grade of retinopathy, oxygen treatment, multiple pregnancy and accompanying systemic diseases were investigated. Results: Of the total 65 premature babies, 41 were male (63%), and 24 were female (37%). ROP developed in 13 (20%) babies. In babies with ROP, the mean GA was 29.7±1.5 (28-32) weeks and the mean BW was 1838±333 g (1530-2600 gr). All babies with ROP received supplementary oxygen therapy. Of the babies with ROP, 5 were stage-1, 6 were stage-2, and 2 were stage-3. Three patients with ROP (4.6%) needed treatment with argon laser photocoagulation (LPC) (n=2) or intravitreal bevacizumab injection (n=1). One of these had respiratory distress syndrome (RDS), one had RDS and sepsis together and one had hydro - cephalus. 21 of 65 babies were one of twin pairs and one was on e of the triplets. There were 5 twin pairs in the ROP group. Conclusion: ROP developed in 20% of the babies with a BW over 1500 g. Nearly 25% of them needed treatment. In conclusion, even if preterm babies have a BW over 1500 g they still have considerable risk for development of ROP, particularly if they have additional systemic diseases or a history of supplementary oxygen treatment, and they should be examined regularly.

Özet

Amaç: Doğum ağırlığı (DA) 1500 gramdan fazla olan preterm bebeklerde prematüre retinopatisi (PR) sıklığının araştırılması. Gereç ve Yöntem: Temmuz 2010 ile Haziran 2012 tarihleri arasında muayene edilen toplam 540 prematüre bebeğe ait kayıtlar geriye dönük incelendi. DA 1500 gramdan büyük olan bebekler çalışmaya dâhil edildi. Bebeklerin DA, gestasyonel yaşları (GY), retinopati evresi, retinopatinin ortaya çıkış zamanı, oksijen tedavisi alıp almadıkları, çoğul gebelik ve eşlik eden sistemik hastalık varlığı not edildi. Bulgular: Çalışmaya dâhil edilen toplam 65 bebeğin 41’i (%63) erkek, 24’ü (%37) kız idi. 13 bebekte PR gelişti. PR gelişen bebeklerde ortalama GY 29.7±1.5 hafta (28-32), ortalama DA ise 1838±333 gr (1530-2600 gr) idi. 13 bebeğin 5’inde evre 1 PR, 6’sında evre 2 PR, 2’sinde evre 3 PR mevcuttu. Tedavi gerektiren hasta sayısı 3 (%4.6) idi. PR gelişen bebeklerin ikisine argon laser fotokoagulasyon (LFK) birine ise intravitreal Bevacizumab enjeksiyonu uygulandı. Bu bebeklerin 1’inde ek hastalık olarak respiratuvar distres sendromu (RDS), diğerinde RDS ve sepsis birlikteliği ve diğerinde ise hidrosefali mevcuttu. PR gelişen bebeklerin hepsi oksijen tedavisi almıştı. PR gelişmeyen 52 bebeğin ise 45’i (%85.6) oksijen tedavisi almıştı. 65 bebeğin 21’i ikiz 1’i üçüz eşiydi. PR gelişen grupta 5 ikiz eşi vardı. Sonuç: Bu çalışmada DA 1500 gram üstünde olan bebeklerde %20 oranında PR gelişmiş ve bu olguların yaklaşık %25’ine tedavi gerekmiştir. Sonuçta DA 1500 gram üzerinde olsa da özellikle ek sistemik hastalığı olan veya oksijen tedavisi almış preterm bebeklerin PR açısından düzenli olarak taranmaları gerektiği akılda tutulmalıdır.

🔖

Cite This Article

ŞAHİN, M., ŞAHİN, A., ACİNGÜ, B. K., ÇINAR, Y., TÜRKÇÜ, F. M., KARABEL, D., YÜKSEL, H., ARI, Ş., ÇAÇA, İ. (2012). Frequency of retinopathy of prematurity in preterm babies with a birth weight more than 1500 gram. Retina-Vitreus, Cilt: 20 - Sayı: 4, 279–282. https://ajindex.com/articles/305096

References (1)

  1. Mc Namara JA, Tasman W. Retinopathy of prematurity. Ophthalmology Clinics of North America 1990;3:413-27. 2.Rudanko SL, Felman V, Laatikainen L. Visual impairment in children born prematurely from 1972 through 1989. Ophthalmol 2003;110:1639-45. 3.Terry TL. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens. I. Preliminary report. Am J Ophthalmol 1942;25:203-4. 4.Onofrey CB,.Feuer WJ, Flynn JT. The outcome of retinopathy of prematurity: screening for retinopathy of prematurity using an outcome predictive programme. Ophthalmology 2001;108:27-34. 5.Seiberth V, Linderkamp O. Risk factors in retinopathy of prematurity. A multivariate statistical analysis. Ophthalmologica 2000;214:131-5. 6.Stout AU, Stout JT. Retinopathy of prematurity. Pediatr Clin N Am 2003;50:77-87. 7.Shohat M, Reisner SH, Kricler R.et al. Retinopathy of prematurity: incidence and risk factors. Pediatrics 1983;72:159-63. 8.Wallace DK, Kylstra JA, Phillips SJ et al. Poor postnatal weight gain: a risk factor for severe retinopathy of prematurity. J AAPOS 2000;4:343-7. 9.The report of a Joint Working Party of The Royal Collegeof Ophthalmologists and the British Association of Perinatal Medicine. Retinopathy of prematurity: guidelines for screeningand treatment. Early Hum Dev 1996;46:239-58. 10.Screening examination of premature infants for retinopathy of prematurity. A joint statement of the American Academy of Pediatric, the American Association for Pediatric Ophthalmology and Strabismus, and the American Academy of Ophthalmology. Ophthalmology 1997;104:888-9. 11.Section on Ophthalmology. American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2006;117:572-6. 12.Arsan S. Prematüre retinopatisi. T Klin Pediatri 2004;2:382-6. 13.Phelps DL. Retinopathy of Prematurity: History, Classification, and Pathophysiology Neo Reviews 2001;2:153-66. 14.Hunter DJ, Mukai S, Hirose T. Advanced retinopathy of prematurity. In: Albert DM, Jacobiec FA (eds). Principles and Practice of Ophthalmology. Philadelphia: WB Saunders; 1994;782-91. 15.Payne JW, Patz A. Current status of retrolental fibroplasia: the retinopathy of prematurity. Ann Clin Res 1979;11:205-21. 16.Zang W, Ito Y, Berlin E et al. Role of hypoxia during normal retinal vessel development and in experimental retinopathy of prematurity.